Back to Search
ESBER NABEEH SAMARA, MD
MD
Urology Physician
NPI: 1255483319IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
23410(OK)
CMS Specialties
PrimaryUROLOGY
Education
UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Class of 2003
Research & Publications (11)
Conceptus dose from involved-field radiotherapy for Hodgkin's lymphoma on a linear accelerator equipped with MLCs.
PMID 19506818·Strahlenther Onkol·2009
8-other
Therapeutic ERCP and pregnancy: is the radiation risk for the conceptus trivial?
PMID 19243762·Gastrointest Endosc·2009
8-other
Infections in a surgical intensive care unit of a university hospital in Greece.
PMID 18775663·Int J Infect Dis·2009
8-other
Trocar site spigelian-type hernia after robot-assisted laparoscopic prostatectomy.
PMID 18619661·Urology·2009
5-case
Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
PMID 16601286·Endocr Relat Cancer·2006
4-observational
Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).
PMID 16052544·J Pharm Sci·2005
4-observational
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
PMID 15897558·Clin Cancer Res·2005
7-preclinical
Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
PMID 14603516·J Pharm Sci·2003
8-other
Single-dose pharmacokinetics of atrasentan, an endothelin-A receptor antagonist.
PMID 11304896·J Clin Pharmacol·2001
3-trial
Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease.
PMID 11304894·J Clin Pharmacol·2001
3-trial
Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles.
PMID 11166404·J Control Release·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5401 N. PORTLAND AVE., SUITE 44D
OKLAHOMA CITY, OK 73112 - Phone
- (405) 943-1137
Quick Facts
- NPI
- 1255483319
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Publications
- 11
Are you this provider?
Claim Your Profile